Submit an Article Guidelines updatedJune 2016
Authors wishing to submit a manuscript to Psychiatric Annals should refer to the following:
At manuscript submission, each author must complete and submit the form below. This combined Author Statement-ICMJE Form for Disclosure of Potential Conflicts of Interest addresses copyright transmittal and any relevant disclosures.
Interactive Author Statement-ICMJE Form for Disclosure of Potential Conflicts of Interest (interactive PDF - preferred)
- Download the form to your computer.
- Open the form in Adobe Acrobat Reader, fill it out, and then save it to your computer.
- Email the form(s) with your manuscript submission, as directed in the guidelines below.
Note. Mac/Safari and Chrome users may have difficulty using the interactive form. These authors should use the Noninteractive Form, which must be printed, completed/signed, and then scanned and emailed with your manuscript submission.
Information for Authors
Journal Description and Mission
Psychiatric Annals is a topical-based monthly publication that publishes Feature (Review) articles on progressive and emerging areas of interest to psychiatrists, psychiatric residents, and other mental health clinicians and professionals who work to find the best treatment modalities for people with mental disorders. The Journal also welcomes Case Challenge articles that descriptively present an unusual diagnosis, followed by an explanation of how the health care team determined the diagnosis.
The Journal offers an author-friendly approach from submission through publication. Psychiatric Annals adheres to the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals (2013) of the International Committee of Medical Journal Editors.
Authorship Criteria and Responsibilities
Criteria for authorship include contribution to:
- Conception and design, or
- Data collection, or
- Analysis and interpretation
- Writing the manuscript, or
- Critical revision of the manuscript
All individuals identified as authors should meet the necessary criteria for authorship listed above, and all individuals who meet the criteria should be identified as authors. Those who do not meet the necessary criteria should be acknowledged (see Acknowledgments). Any issues related to authorship must be resolved before the manuscript is submitted to the Journal.
Authors should be accountable for the portions of the manuscript to which they have contributed. They should also have confidence in the integrity of the contributions of all other authors. All authors should have read the final manuscript prior to submission and be aware of its submission to the Journal.
One author must be identified as the corresponding author, who is responsible for (1) ensuring all authors meet the authorship criteria and complete the required Author Statement-ICMJE Form for Disclosure of Potential Conflicts of Interest; (2) submitting the manuscript to the Journal and serving as the main contact during the review process; and (3) performing any related activities if the manuscript is accepted, such as reviewing proofs of the edited manuscript and answering editorial queries. The corresponding author will be identified as the primary contact in the published article.
Order of authorship must be determined and agreed upon by all authors before manuscript submission. Any disagreements should be resolved before submitting the manuscript. Changes in authorship (ie, order, addition, and/or deletion of authors) must be approved by all authors. Requests for changes in authorship after initial manuscript submission and before publication are required in writing (email preferred) signed by all authors.
Any individuals who contributed to the manuscript but do not meet the necessary criteria for authorship should be acknowledged. Acknowledgments should be limited to those who helped extensively, such as providing statistical help or translating references.
Manuscripts are accepted with the understanding that they have not been previously published (in print or online) and are not under simultaneous consideration by another publication. Previous publication of the abstract is acceptable. Publication of data or a detailed report in news media constitutes prior publication. Accepted manuscripts become the permanent property of the Journal and will not be published until the Author Statement-ICMJE Form for Disclosure of Potential Conflicts of Interest has been completed in full by each author.
Conflict of Interest and Sponsorship
If any author has a financial conflict of interest in the subject matter in the manuscript, this must be indicated. If the manuscript discusses in any way a drug, a device, equipment, or an instrument, the authors must state whether or not they have any commercial or proprietary interest in the product or company. Likewise, they must reveal whether they have any financial interest as a consultant, reviewer, or evaluator.
If applicable, authors should describe the role of the study sponsor, if any, in study design; collection, analysis, and interpretation of data; writing the report; and the decision to submit the report for publication. If the supporting source had no such involvement, the authors should so state. If applicable, authors must declare whether they had assistance with study design, data collection, data analysis, or manuscript preparation. If the manuscript reports on a registered clinical trial and has been assigned a trial registration number from a public trials registry, authors should provide this information.
Protection of Identifiable Subjects
If subjects’ personal details are provided, measures should be taken to protect subjects’ identity. If photographs are submitted with a manuscript, permission to publish must be obtained in writing from all individuals pictured. Measures to conceal the identity of an individual in a photograph, such as placing black bars over the person’s eyes, should not be used.
Psychiatric Annals considers Feature (Review) and Case Challenge article submissions; the journal does not consider original research or studies based on animal models. Manuscripts should be clinically based, not academic.
Manuscripts should be prepared following the AMA Manual of Style, 10th edition, and spelling should reflect Dorland’s Illustrated Medical Dictionary. Manuscripts must be double-spaced, with 1-inch margins.
Manuscript titles should be concise, specific, and informative and should contain the key points of the work. Overly general titles, as well as questions and declarative sentences, should be avoided.
Use of abbreviations should be limited to those that are commonly understood without explanation. All abbreviations must be spelled out at first mention in the text. Pharmaceuticals should be referred to by their generic names. Device manufacturers and their locations should appear in parentheses following the mention of devices.
Title Page: Each manuscript should be submitted with a title page, which should include the title of the manuscript; each author’s name, academic degree, academic affiliation, and job title; the corresponding author’s complete mailing address and email; grant information; disclaimer/conflict of interest information; and acknowledgments.
Abstract: Each article must have an unstructured abstract of no more than 150 words.
References: References should be limited to no more than 30 sources. References must be cited consecutively in the text with superscript numbers (or parenthetically for unpublished data or personal communication) and subsequently listed in the reference section at the end of the text, per the AMA’s Manual of Style, 10th edition. Do not use footnotes or endnotes. Authors are responsible for the accuracy of references, particularly author names and page numbers.
Unpublished data and personal communications should NOT be listed as references but mentioned parenthetically in the text.
Abbreviations of the names of journals should conform to PubMed/MEDLINE. The titles of those journals that are not listed in PubMed/MEDLINE must be provided in full. Journal titles should be cited as they existed at the time of publication.
Tables: Each table should be numbered, have a concise but fully descriptive title, and be cited consecutively in the text. Each main column in the table should have a heading. All abbreviations (even those that are common) used in tables should be explained in a legend. Material that is in the tables should not be repeated in the text.
All tables should be submitted as separate files and not pasted into the manuscript document itself. Case Challenge manuscripts are limited to no more than 2 tables.
Figures, Photos, Illustrations: Including illustrations, photographs, charts, and other figures is highly encouraged. Original illustrations are preferred. Each illustration must be numbered and cited consecutively in the text. If applicable, arrows or asterisks can be present on illustrations for identification of specified areas that are discussed in the legend. Case Challenge manuscripts are limited to no more than 2 figures, photos, and/or illustrations.
- Permission: Drawings or computer-generated images submitted with a manuscript require permission to publish from the artist. Identifiable photographs of patients must be accompanied by proof of informed consent. Authors must disclose whether any figures or tables have been previously published; such materials must be accompanied by a letter of permission from the publisher, which extends non-exclusive worldwide rights to reprint the material for all forms of media now or hereafter developed to SLACK Incorporated. Content from U.S. government websites (eg, NIH, CDC, USDHHS) is in the public domain and generally can be used without permission. However, some content on these sites may be from another source, in which case permission must be obtained from the copyright holder.
- Legends: All figure legends should be numbered in the order in which they are referred to in the text. A legend should be a brief description that allows the illustration to be fully understood. All abbreviations (even those that are common) used in the figures/illustrations should be explained in the legend.
- Digital Requirements: Digital images should be high resolution (at least 300 dpi) and saved in JPEG or TIFF format. Image files should be separate from manuscript text files. Images embedded in Word files and PowerPoint® slides are not acceptable. Each image must be a separate, stand-alone file, named to match the figure number listed in the text (eg, Jonesfig1.tif).
Feature (Review) Article Manuscripts
Organization of Feature (Review) Article manuscripts should be as follows: Title Page, Abstract, Introduction, Review/Discussion (can include first-, second-, and third-level headings), Summary/Conclusion, References, and Figure Legends.
Text: The manuscript text should be at least 1500 words and not exceed 2500 words (including references).
References: Feature (Review) Article references should be limited to no more than 30 sources. See the General Guidelines for more details.
Case Challenge Manuscripts
Organization of Case Challenge manuscripts should be as follows: Title Page, Case Description, Diagnosis, Discussion, Conclusion, References, and Figure Legends. IMPORTANT NOTE: Do not reveal the diagnosis in the Case Challenge title or in any section of the text prior to the Diagnosis section of the manuscript.
Text: The manuscript text should be at least 1200 words and not exceed 1500 words (including references).
References: References for each article should be limited to no more than 20 sources. See the General Guidelines for more details.
Tables and Figures: Tables and figures in Case Challenges are limited to no more than two.
Manuscripts should be submitted as a Microsoft Word document (without track changes) via email to the editorial office.
All manuscripts are accepted at the discretion of the Editor-in-Chief and members of the journal’s Editorial Board. Authors are notified by email as soon as possible (within 1-6 months) regarding manuscript decision.
Peer reviewers are required to maintain confidentiality about the manuscripts they review and must not divulge any information about a specific manuscript or its contents without prior permission.
Policy on Research Misconduct
The publisher and editor will take reasonable steps to identify and prevent the publication of papers where research misconduct has occurred, including but not limited to plagiarism, citation manipulation, and data falsification/fabrication. Per journal policy, final manuscript acceptance is contingent upon successfully passing a plagiarism software check. If an allegation of research misconduct is made related to an article published in the Journal, the publisher and editor will follow the guidelines provided by the Committee on Publication Ethics (COPE) to address such allegations.
Copyediting and Author Proofs
All accepted manuscripts are professionally copyedited to adhere to the AMA Manual of Style, 10th edition, and journal style. The Journal reserves the right to delete extraneous or excess material and change or add titles and headings.
Proofs of the edited article are provided to the corresponding author for review and approval. Rewriting the manuscript or making frivolous changes at the proof stage is unacceptable. Authors are responsible for all statements made in their work, including changes made during copyediting and production that are approved by the corresponding author.
Letters to the Editor
Letters to the Editor are correspondence regarding articles that have been published in the journal. Letters regarding a previously published article must be submitted within 12 months of the article’s publication to be considered for possible publication, and the author of that article will be given the opportunity to respond.
Letters should be no more than 500 words, with no more than 5 references and no more than 1 figure. Letters may be edited for clarity or length, and letter authors must disclose any competing or conflicting interests. All letters are published at the Editor’s discretion. Letters should be submitted to the editorial office.
Corrections and Errata
Requests to publish corrections should be emailed to the editorial office. Corrections and errata are reviewed by the Editor-in-Chief, published promptly, and linked online to the original article.
Article reprints are available through Wright's Media.
The publisher works with Portico to ensure electronic backup and preservation of access to Psychiatric Annals content.
Questions regarding the Journal should be directed to the editorial office.
Scholarly Uses of Journal Articles
Acceptable uses of SLACK Incorporated journal articles that are not published open access are outlined in the chart below (click to enlarge).
Commercial Uses and/or Systematic Distribution
Authors of non-open access articles published in SLACK Incorporated journals may reuse the articles only for the scholarly purposes as set out above but may NOT use or post them for commercial purposes or under policies or other mechanisms designed to aggregate and openly disseminate manuscripts or articles. This includes the use or posting of articles for commercial gain or to substitute for the services provided directly by the journal, including the posting by companies of their employee-authored works for use by customers of such companies (eg, pharmaceutical companies and physician prescribers); commercial exploitation, such as directly associating advertising with such postings; the charging of fees for document delivery or access; and the systematic distribution to others via email lists or list servers, whether for a fee or for free.
Public Access Policy for Non-Open Access Articles
SLACK Incorporated’s journal copyright agreements enable authors funded by the National Institutes of Health (NIH) to deposit their accepted manuscripts to PubMed Central for posting 12 months following publication by SLACK Incorporated. The agreement also allows posting of accepted manuscripts on authors’ institutional repositories, with the exception of open access repositories, 12 months following publication by SLACK Incorporated. Authors should include a link to the final published article on the journal website. SLACK Incorporated will retain copyright for these articles, which prohibits republication elsewhere, and SLACK Incorporated will retain the right to charge a fee for the final published versions of these articles in whatever format they appear.
For uses that do not fall within the situations listed above, please visit healio.com/permissions.
Questions? Contact: SLACK Customer Service, 1-800-257-8290 (856-848-1000 in NJ) or firstname.lastname@example.org